Large-scale testing (Phase 3)Study completedNCT06211478What this trial is testingRole of Vitamin E in Gaucher Disease PatientsWho this might be right forGaucher Disease Ain Shams University 40
Not applicableLooking for participantsNCT05992532What this trial is testingGammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple MyelomaWho this might be right forGaucher DiseaseAcid SphingoMyelinase Deficiency Fundación Española de Hematología y Hemoterapía 210
Testing effectiveness (Phase 2)UnknownNCT01951989What this trial is testingIntra-monocyte Imiglucerase Kinetics in Gaucher DiseaseWho this might be right forGaucher Disease University Hospital, Clermont-Ferrand 60
Not applicableWithdrawnNCT04189601What this trial is testingComplement Activation in the Lysosomal Storage DisordersWho this might be right forFabry DiseaseGaucher DiseaseNiemann-Pick Disease, Type C+1 more Melbourne Health
Not applicableUnknownNCT06539169What this trial is testingFLOWER: Following Longitudinal Outcomes With Epidemiology for Rare DiseasesWho this might be right forAlpha-ThalassemiaBeta-ThalassemiaAmyloidosis+14 more xCures 1,000
Not applicableLooking for participantsNCT03240653What this trial is testingGaucherite - A Study to Stratify Gaucher DiseaseWho this might be right forGaucher Disease, Type IGaucher Disease, Type III Cambridge University Hospitals NHS Foundation Trust 250
Not applicableUnknownNCT03811496What this trial is testingBiomarker Analysis for GBA Associated Parkinson's DiseaseWho this might be right forParkinson DiseaseGaucher Disease Lysosomal and Rare Disorders Research and Treatment Center, Inc. 100
Large-scale testing (Phase 3)Looking for participantsNCT07223944What this trial is testingA Gaucher Disease Gene Therapy Trial With FLT201Who this might be right forGaucher Disease Type 1 Spur Therapeutics 45
Large-scale testing (Phase 3)Study completedNCT01074944What this trial is testingEliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE)Who this might be right forGaucher Disease Genzyme, a Sanofi Company 170
Testing effectiveness (Phase 2)Study completedNCT00433147What this trial is testingAT2101 (Afegostat Tartrate) in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement TherapyWho this might be right forGaucher Disease, Type 1Type 1 Gaucher DiseaseGaucher Disease Amicus Therapeutics 30
Not applicableNot Yet RecruitingNCT05669729What this trial is testingA Survey to Assess Participants', Caregivers', and Nurses' Use and Understanding of Educational Material on Velaglucerase Alfa (VPRIV) Home InfusionWho this might be right forGaucher Disease Takeda 60
Not applicableUnknownNCT05536388What this trial is testingDrug Discovery for Parkinson's With Mutations in the GBA GeneWho this might be right forParkinson DiseaseGaucher DiseaseHealthy+1 more New York Stem Cell Foundation Research Institute 60
Not applicableStudy completedNCT05908656What this trial is testingImplementation and Evaluation of a Rare Disease Algorithm to Identify Persons at Risk of Gaucher Disease Using Data From Electronic Health Records (EHRs) in the United States (Project Searchlight)Who this might be right forGaucher Disease Sanofi 13
Not applicableWithdrawnNCT01331642What this trial is testingBiomarker for Gaucher Disease: BioGaucher (BioGaucher)Who this might be right forSplenomegalyHepatomegaly CENTOGENE GmbH Rostock
Early research (Phase 1)Study completedNCT01747980What this trial is testingSafety and Pharmacokinetics of Oral PRX-112 in Gaucher Disease PatientsWho this might be right forGaucher Disease Protalix 16
Post-approval studies (Phase 4)Study completedNCT04718779What this trial is testingEnzyme Replacement Therapy (VPRIV) in People With Type 1 Gaucher Disease Who Were Previously Treated With Substrate Reduction TherapyWho this might be right forGaucher Disease Takeda 4
Early research (Phase 1)Study completedNCT06193304What this trial is testingEvaluate Pharmacokinetic Parameters and Safety of Eliglustat Absorption Through the MouthWho this might be right forGaucher's Disease Sanofi 6
Not applicableEnded earlyNCT04836377What this trial is testingA Long-Term Follow-up Study of Subjects With Gaucher Disease Who Previously Received AVR-RD-02Who this might be right forType 1 Gaucher Disease AVROBIO 4
Early research (Phase 1)Study completedNCT02536937What this trial is testingThe Effects of Renal Impairment on the Pharmacokinetics and Tolerability of Eliglustat TartrateWho this might be right forGaucher Disease Sanofi 32
Large-scale testing (Phase 3)Study completedNCT00553631What this trial is testingStudy of Gene-Activated® Human Glucocerebrosidase (GA-GCB) ERT Compared With Imiglucerase in Type I Gaucher DiseaseWho this might be right forGaucher Disease, Type 1 Shire 34